Treatment of obesity: need to focus on high risk abdominally obese patients
By J. Despres, I. Lemieux, D. Prud'homme. British medical journal, 2001
929 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Pharmacology, Pharmacy
View Paper: https://www.semanticscholar.org/paper/58dd1bf5ef16d838974ee484224e0b695c9791fe
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Pharmacology
In Pharmacy
Citations in the corpus
- Mechanisms linking obesity with cardiovascular disease (2006, background): “Moreover, visceral fat correlates with cardiovascular risk factor”
- Stress and Obesity. (2019, background): “Abdominal obesity is a particularly toxic pattern of fat deposition and predicts poor metabolic and cardiovascular health in longitudinal studies (Després et al. 2001).”
- Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. (2002, background): “, fat in the visceral and sc abdominal region) and features of the IRS (71), although the causal nature of this relationship (72, 73) and the relative importance of visceral vs.”
- Pathophysiology of human visceral obesity: an update. (2013, methodology): “The dyslipidemic state frequently observed in patients with visceral obesity is a key feature of the clustering abnormalities of the metabolic syndrome and has been extensively described in the literature (114, 115, 197, 263).”